Skip to content
RollCall logo

Staff

Emily Kopp

The Latest From Emily Kopp
N95 face masks are displayed at a Home Depot store in Orlando, Fla., on the day that the CDC updated its guidance on masks for the general public.

CDC has backlog of applications from manufacturers of N95 masks

By Emily Kopp
Posted January 19, 2022 at 12:05pm
FDA Commissioner Robert Califf will make the final decision on removing the only available drug aimed at lowering the risk of premature births.

Senate Health panel advances Califf to lead FDA

By Emily Kopp
Posted January 13, 2022 at 1:35pm
The move comes as an omicron surge has driven case numbers to record highs. Above, a woman gets a booster on Capitol Hill in October 2021.

FDA lowers eligibility age for Pfizer-BioNTech boosters to 12

By Emily Kopp
Posted January 3, 2022 at 2:50pm
President Joe Biden speaks about the omicron variant of the coronavirus in the State Dining Room of the White House on Tuesday.

Biden issues dire warning for unvaccinated as omicron surges before holidays

By Emily Kopp
Posted December 21, 2021 at 4:15pm
Sgt. Demetrius Roberson administers a COVID-19 vaccine to a soldier on Sept. 9 in Fort Knox, Ky.

Biden to mobilize military to hospitals for omicron winter surge

By Emily Kopp
Posted December 21, 2021 at 7:13am
Pharmacist Elizabeth Alvarez administers a Pfizer-BioNTech COVID-19 vaccine at Grubb’’s Pharmacy in Washington on Nov. 8.

Burnout among pharmacists slows COVID-19 booster shots

By Emily Kopp and Ariel Cohen
Posted December 15, 2021 at 6:29am
Vials of the Pfizer-BioNTech COVID-19 vaccine sit on a table.

Omicron partially evades protection from Pfizer-BioNTech vaccine

By Emily Kopp
Posted December 8, 2021 at 10:09am
Rochelle P. Walensky, director of the Centers for Disease Control and Prevention, earlier this year on Capitol Hill. During an interview with CQ/Roll Call Wednesday, Walensky called for funding and authority to better respond to public health crises.

Omicron could overtake delta within weeks, experts say

By Emily Kopp
Posted December 7, 2021 at 3:01pm
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, arrives earlier this year to testify before a House hearing. He spoke Wednesday about the new COVID-19 variant.

First US case of omicron variant detected

By Emily Kopp
Posted December 1, 2021 at 3:07pm
Hattie Pierce, 75, gets a Pfizer COVID-19 vaccine booster shot from Dr. Tiffany Taliaferro at the Capitol Hill Safeway in Washington on Oct. 4.

FDA to sidestep advisers on boosters-for-all approval

By Emily Kopp
Posted November 17, 2021 at 6:01am
Robert Califf, shown at his previous confirmation hearing in November 2015, was nominated to again lead the FDA.

Biden taps Califf as FDA commissioner

By Emily Kopp
Posted November 12, 2021 at 10:56am
A COVID-19 vaccination record card. Proof of vaccination or negative test results will be needed from workers at businesses that employ 100 workers or more under a new OHSA rule.

Employers must require COVID-19 shots or tests by January under federal rule

By Emily Kopp
Posted November 4, 2021 at 8:45am
Colored tape on the floor guides COVID-19 vaccine recipients to the vaccine administration room and the post-vaccine waiting room at a neighborhood vaccination center in Washington earlier this year. The FDA on Friday authorized a COVID-19 vaccine for children who are 5 through 11 years old.

FDA authorizes COVID-19 vaccines for younger kids

By Emily Kopp
Posted October 29, 2021 at 4:00pm
Recent revelations complicate White House chief medical adviser Anthony Fauci’s previous statements that the NIH never funded research projects in Wuhan that gave pathogens new properties with the potential to cause any kind of pandemic.

NIH grantee in Wuhan faces questions, deadline for more information on research

By Emily Kopp
Posted October 22, 2021 at 6:17pm
A woman receives a Pfizer COVID-19 booster shot at the Safeway on Capitol Hill on Oct. 4.

FDA authorizes broad, flexible COVID-19 booster policy

By Emily Kopp
Posted October 20, 2021 at 8:07pm
HHS Secretary Xavier Becerra said the regulation is personal to him, as his mother had been hoodwinked and struggled to get her money back from an unscrupulous manufacturer.

FDA announces ‘landmark’ action to make hearing aids cheaper

By Emily Kopp
Posted October 19, 2021 at 4:45pm
Colored tape on the floor guides COVID-19 vaccine recipients at a neighborhood vaccination center in Washington earlier this year.

FDA advisers back Johnson & Johnson vaccine booster

By Emily Kopp
Posted October 15, 2021 at 2:49pm, Updated at 4:43pm
Throughout the COVID-19 pandemic, the FDA’s decisions have faced scrutiny as its regulators have made crucial decisions over booster shots and pediatric vaccinations.

FDA advisers recommend Moderna COVID-19 booster shots

By Emily Kopp
Posted October 14, 2021 at 4:41pm
Robert Califf testifies during his nomination hearing to be Food and Drug Administration commissioner before the Senate Health, Education, Labor and Pensions Committee in November 2015. Califf is under consideration to again be nominated to lead the FDA.

Report: White House considering Robert Califf as FDA commissioner

By Ariel Cohen and Emily Kopp
Posted October 14, 2021 at 2:08pm
A pharmacist prepares to give a COVID-19 booster vaccination.

Some health experts confused about administration’s booster goal

By Emily Kopp
Posted October 13, 2021 at 9:53am
President Joe Biden acknowledged his stance on mandates has shifted.

Biden pushes back on opposition to vaccine mandates

By Emily Kopp
Posted October 7, 2021 at 8:00pm
Chaos at the Food and Drug Administration’s Office of Vaccines Research and Review comes amid a critical month for policymakers.

FDA’s internal turmoil could impact boosters, shots for kids

By Emily Kopp
Posted October 6, 2021 at 6:29am
President Joe Biden is seen on a screen Monday receiving his COVID-19 booster shot at the White House.

White House says 2 million people got COVID-19 boosters this week

By Emily Kopp
Posted October 1, 2021 at 3:06pm
A woman fills a prescription at the Borinquen Health Care Center in Florida.

Nonprofit linked to PhRMA behind ads opposing drug pricing changes

By Emily Kopp
Posted September 30, 2021 at 8:27am
Colored tape on the floor guides COVID-19 vaccine recipients to the vaccine administration room at a neighborhood vaccination center in Washington earlier this year. The FDA authorized a third shot for the Pfizer vaccine on Wednesday.

FDA authorizes Pfizer COVID-19 booster for people at high risk

By Emily Kopp
Posted September 22, 2021 at 8:32pm
Vials of the Pfizer-BioNTech COVID-19 vaccine sit on a table.

FDA advisers reject third shots for all, back them for vulnerable

By Emily Kopp
Posted September 17, 2021 at 5:15pm
A nurse prepares to administer a Pfizer COVID-19 booster shot at UCI Medical Center in Orange, Calif., on Aug. 19.

COVID-19 booster debate rages days before target rollout date

By Emily Kopp
Posted September 15, 2021 at 6:29am
Doses of the Pfizer-BioNtech COVID-19 vaccine.

Biden plots vaccine booster shots

By Emily Kopp
Posted August 18, 2021 at 11:09am
Pharmacist LaChandra McGowan prepares a dose of the Pfizer COVID-19 vaccine on Aug. 12 in New Orleans. The Centers for Disease Control and Prevention will revise its guidance and suggest that the most vulnerable patients get a COVID-19 booster shot.

CDC’s vaccine advisers back COVID-19 booster for the vulnerable

By Emily Kopp
Posted August 13, 2021 at 3:44pm
Rochelle Walensky, director of the Centers for Disease Control and Prevention, shown earlier this year.

CDC report shows vaccinated people can spread COVID-19

By Emily Kopp
Posted July 30, 2021 at 2:02pm
President Joe Biden is requiring federal workers and contractors to declare their COVID-19 vaccination or use additional public health precautions.

Biden asks federal workers to disclose vaccination status

By Mary Ellen McIntire and Emily Kopp
Posted July 29, 2021 at 4:46pm
Vials of the Pfizer-BioNTech COVID-19 vaccine.

Biden bid for federal workers to get COVID-19 shots prompts debate

By Emily Kopp and Sandhya Raman
Posted July 28, 2021 at 9:25pm
Top infectious disease expert Anthony Fauci responds to accusations by Sen. Rand Paul as he testifies before the Senate Health, Education, Labor, and Pensions Committee about the origin of COVID-19 on Tuesday.

Experts weigh in on risky Wuhan study that Fauci, Paul debated

By Emily Kopp
Posted July 23, 2021 at 7:45pm
Sen. Roger Marshall, R-Kan., holds a model of a coronavirus spike protein at a news conference with the GOP Doctors Caucus on Thursday.

GOP pro-vaccine message clouded by emphasis on choice and privacy

By Emily Kopp
Posted July 23, 2021 at 5:20pm
Senate Majority Leader Charles E. Schumer holds a news conference Wednesday to unveil draft legislation that would decriminalize cannabis.

Senate Democratic leaders unveil draft bill to legalize marijuana

By Lauren Clason and Emily Kopp
Posted July 14, 2021 at 2:08pm
This aerial view shows the P4 lab on the campus of the Wuhan Institute of Virology in China’s central Hubei province on May 27, 2020.

3 questions experts say need to be asked about pandemic’s origin

By Emily Kopp
Posted June 23, 2021 at 5:31am
Secretary of Labor Marty Walsh speaks at a union rally June 2 in Allentown, Pa.

OSHA issues safeguards for health workers, but goals for others

By Emily Kopp
Posted June 10, 2021 at 3:56pm
President Joe Biden prepares to address U.S. Air Force personnel and their families stationed at Royal Air Force Mildenhall, Suffolk, England on Wednesday.

Biden expected to announce US will buy 500 million Pfizer vaccine doses for the world

By Emily Kopp and Niels Lesniewski
Posted June 9, 2021 at 5:21pm
President Joe Biden speaks Wednesday from the Eisenhower Executive Office Building in Washington on a new effort to boost COVID-19 vaccinations over the next month.

White House dangles free child care and beer in vaccination push

By Emily Kopp
Posted June 2, 2021 at 4:09pm
A kindergartner removes her mask before having her portrait made during “picture day” at Rogers International School in Stamford, Conn., on Sept. 23, 2020.

COVID-19 forecast murky as states drop mask requirements

By Lauren Clason and Emily Kopp
Posted June 2, 2021 at 6:31am
Rep. Mariannette Miller-Meeks (R-IA) listens as Robert Kramer, president and CEO of Emergent BioSolutions, speaks via videoconference during the hearing on the company's handling of COVID-19 vaccines.

Executives defend quality control at troubled COVID-19 vaccine plant

By Emily Kopp
Posted May 19, 2021 at 4:52pm
Workers process meat at Old Fashion Country Butcher in Santa Paula, Calif., in May 2020. The North American Meat Institute is scheduled to meet with federal officials to discuss COVID-19 worker protection rules.

Delayed COVID-19 worker protections attract crush of lobbyists

By Emily Kopp
Posted May 12, 2021 at 6:15am
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to the president, arrives Tuesday to testify before senators on the administration's coronavirus response.

Biden health team plans for potential COVID-19 vaccine booster shots

By Emily Kopp
Posted May 11, 2021 at 5:10pm
President Joe Biden at his address to the joint session of Congress on April 28.

Biden urges at least 70 percent of US adults to get first shot by July 4

By Emily Kopp
Posted May 4, 2021 at 3:59pm
More federal involvement in the vaccination push was a central component of President Joe Biden’s COVID-19 plan, but FEMA has been under pressure since being deployed at mass vaccination sites nationwide.

FEMA’s tasks pit COVID-19 vaccinations against hurricane prep

By Emily Kopp
Posted April 28, 2021 at 6:30am
Loaded doses of Johnson & Johnson Janssen COVID-19 vaccine are pictured at Grubb's Pharmacy on Capitol Hill April 12.

FDA finds more problems with Johnson & Johnson contractor

By Emily Kopp
Posted April 21, 2021 at 4:34pm
While vaccination was challenging in the early months because of low supply, a lack of vaccinators and varied eligibility, getting a vaccine has gotten simpler.

White House fears bumpy rollout deterring people from COVID-19 vaccine shots

By Emily Kopp
Posted April 19, 2021 at 3:06pm
Johnson & Johnson’s single-dose COVID-19 vaccine was paused after extremely rare reports of blood clots in six patients.

Johnson & Johnson pause slows vaccines for homeless, homebound

By Emily Kopp
Posted April 16, 2021 at 10:44am
A box of Johnson & Johnson's Janssen COVID-19 vaccine doses are pictured at Grubb's Pharmacy on Capitol Hill.

White House resists pressure to space out COVID-19 vaccine doses

By Emily Kopp
Posted April 13, 2021 at 11:44am
Phuc Tran of Northeast Washington, D.C., receives the Johnson & Johnson COVID-19 vaccine from Heidi Johnson, pediatric nurse practitioner, at Grubb's Pharmacy on Capitol Hill on Monday, April 12, 2021.

States react to short Johnson & Johnson COVID-19 vaccine pause

By Ariel Cohen and Emily Kopp
Posted April 13, 2021 at 11:24am, Updated at 3:44pm
President Joe Biden stands next to a man about to be vaccinated as he tours the Neighborhood Health's pop-up Covid-19 vaccination site at the Virginia Theological Seminary in Alexandria, Virginia.

Biden COVID-19 vaccination timeline ends confusion about state criteria

By Niels Lesniewski and Emily Kopp
Posted April 6, 2021 at 4:05pm
One-shot doses of the Johnson and Johnson COVID-19 vaccine are prepared on Thursday.

Company with Trump administration tie may be COVID-19 vaccine bottleneck

By Emily Kopp
Posted March 26, 2021 at 9:57am
“We do have a lot of challenges in front of us with regard to the high level of daily infections,” White House senior medical adviser Anthony Fauci said.

Fauci: US may ‘turn the corner’ on virus, but spring break poses big risks

By Emily Kopp
Posted March 24, 2021 at 6:06pm
Johnson & Johnson’s single-dose COVID-19 vaccine was paused after extremely rare reports of blood clots in six patients.

Johnson & Johnson under pressure to deliver promised vaccine doses to states

By Emily Kopp
Posted March 23, 2021 at 3:12pm
Nema Manuel, principal of Heather Hills Elementary School, conduct a materials distribution of books and supplies for parents to pick up for distance learning in Bowie, Md., on August 26, 2020.

CDC revises distancing advice in schools in bid to open classrooms

By Mary Ellen McIntire and Emily Kopp
Posted March 19, 2021 at 12:00pm, Updated at 2:32pm

Watch: N95 masks are piling up as nurses reuse PPE

By Emily Kopp and Thomas McKinless
Posted March 2, 2021 at 4:28pm
Employees make respiratory masks in a family-owned medical equipment factory in north Miami, Florida on Feb. 15, 2021.

Masks stack up in US warehouses as nurses reuse N95 respirators

By Emily Kopp
Posted March 1, 2021 at 4:35pm
Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech is reflected in the glass of a fume hood as she prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on Dec. 15 in Aurora, Colorado.

FDA advisers recommend third COVID-19 vaccine

By Emily Kopp
Posted February 26, 2021 at 5:57pm
A sign at a Washington grocery store notifies customers Tuesday that COVID-19 vaccines are not yet available. Several states say they are experiencing delays of vaccines made by Moderna.

Winter weather delays vaccine shipments to all 50 states

By Emily Kopp and Sandhya Raman
Posted February 19, 2021 at 2:48pm
An empty classroom is pictured at Heather Hills Elementary School in Bowie, Md.

CDC releases road map on reopening schools

By Emily Kopp
Posted February 12, 2021 at 5:14pm
Sen. Maggie Hassan says she opposes any FDA commissioner nominee who has not learned from the opioid crisis.

FDA commissioner race could test pharmaceutical industry’s sway

By Emily Kopp
Posted February 11, 2021 at 4:57pm
A man helped his mother get the vaccine shot from a nurse at Gillette Stadium in Foxborough, Mass.

US vaccine effort opts for stadium clinics over doctors’ offices

By Emily Kopp
Posted February 8, 2021 at 8:59am
A vacant classroom in South Hadley, Mass.

Vaccine shortage complicates return to classrooms

By Mary Ellen McIntire and Emily Kopp
Posted February 2, 2021 at 10:02am
A new Johnson & Johnson COVID-19 vaccine may soon be available. The U.S. vaccine supply is currently limited to a Pfizer-BioNTech COVID-19 vaccine, shown here, and another vaccine by Moderna.

Johnson & Johnson COVID-19 vaccine less effective than others but offers one-shot solution

By Emily Kopp and Ariel Cohen
Posted January 29, 2021 at 9:49am
President Joe Biden speaks about the COVID-19 response on January 22, 2021.

Biden inherits Trump’s unique health care agenda

By Lauren Clason, Emily Kopp, Mary Ellen McIntire and Sandhya Raman
Posted January 27, 2021 at 5:30am
Christopher Rodriguez, director of the District of Columbia Homeland Security and Emergency Management Agency, receives a COVID-19 vaccine administered by nurse Rishea Casselle at the Kaiser Permanente Capitol Hill Medical Center in Washington on Jan. 25, 2021.

Biden announces distribution of more COVID-19 vaccine supplies

By Emily Kopp
Posted January 26, 2021 at 5:09pm
US President Joe Biden signs three documents including an Inauguration declaration, cabinet nominations and sub-cabinet noinations, as US Vice President Kamala Harris (R) watches in the Presidents Room at the US Capitol after the inauguration ceremony to making Biden the 46th President of the United States in Washington, DC, USA, 20 January 2021.

Here’s the health care landscape Trump left for Biden

By Lauren Clason, Emily Kopp and Thomas McKinless
Posted January 26, 2021 at 8:30am
President Joe Biden speaks about his administration’s COVID-19 response plan at the White House on Thursday, Jan. 21, 2021.

US issues national pandemic plan, a year after its first COVID-19 case

By Emily Kopp
Posted January 21, 2021 at 4:47pm
President-elect Joe Biden attends a coronavirus briefing with former FDA Commissioner David Kessler and other health advisers on Oct. 28, 2020, in Wilmington, Del.

Former FDA official to help lead vaccine oversight for Biden

By Emily Kopp
Posted January 15, 2021 at 10:47am
When COVID-19 vaccinations started in December, federal officials said they would ship the first doses of the Moderna vaccine to 3,285 U.S. locations, fewer than estimated in October.

COVID-19 vaccines sit at hospitals as doctors, pharmacies await doses

By Emily Kopp
Posted January 13, 2021 at 7:00am
UNITED STATES - JANUARY 6: Reps. Lucille Roybal-Allard, D-Calif., and Annie Kuster, D-N.H., center, take cover as rioters attempt to break in to the joint session of Congress to certify the Electoral College vote on Wednesday, January 6, 2021. (Photo By Tom Williams/CQ Roll Call)

More lawmakers test positive after superspreader event during Capitol riot

By Thomas McKinless and Emily Kopp
Posted January 12, 2021 at 1:28pm
A nurse prepares a vaccine.

Federal officials, behind schedule, plan COVID-19 vaccination changes

By Emily Kopp
Posted January 12, 2021 at 12:48pm
Workers clean up in the Capitol a day after a mob assaulted the building.

Concern grows over potential COVID-19 superspreader event during Capitol riot

By Emily Kopp
Posted January 11, 2021 at 6:08pm
Pfizer's COVID-19 vaccine is pictured at Rady Children's Hospital before it's placed back in the refrigerator in San Diego on Dec. 15, 2020.

FDA authorizes second COVID-19 vaccine

By Emily Kopp and Mary Ellen McIntire
Posted December 18, 2020 at 7:55pm
Medical staff at Howard University prepare COVID-19 vaccination doses for hospital staff on Monday.

Moderna COVID-19 trial data shows vaccine is broadly effective

By Emily Kopp
Posted December 15, 2020 at 12:17pm
The outside of the Food and Drug Administration headquarters in White Oak, Md.

FDA authorizes first COVID-19 vaccine

By Emily Kopp
Posted December 11, 2020 at 10:06pm
A woman receives a COVID-19 vaccination as part of a study at Research Centers of America on Aug. 7, 2020 in Hollywood, Fla.

What we still don’t know about the Pfizer/BioNTech COVID-19 vaccine

By Emily Kopp
Posted December 11, 2020 at 3:54pm
President Donald Trump speaks during his Operation Warp Speed Vaccine Summit in Washington Tuesday.

‘America First’ order unlikely to save vaccines for Americans

By Emily Kopp
Posted December 8, 2020 at 7:43pm
A cannabis logo with Santa hat is seen in Dublin, Ireland, on Dec. 3.

House votes to decriminalize marijuana

By Emily Kopp
Posted December 4, 2020 at 7:52am, Updated at 1:29pm
UNITED STATES - NOVEMBER 17: An area is set up in the House Visitors Center for Congressional members and staffers to tested for coronavirus in Washington on Tuesday, Nov. 17, 2020. (Photo by Caroline Brehman/CQ Roll Call)

What we know now about COVID-19 vaccine authorization and distribution

By Emily Kopp and Thomas McKinless
Posted December 1, 2020 at 11:35am
A sign at the entrance to a pharmacy in Burbank, Calif., tells customers that a COVID-19 vaccine is not yet available. While multiple possible vaccines are nearing approval, several steps remain before they could be distributed.

FDA authorization of COVID-19 vaccines would set off a scramble

By Emily Kopp
Posted November 30, 2020 at 9:26am
Janet Woodcock of the FDA testifies before Congress in 2016. She spoke to reporters this week about COVID-19 treatments.

Drug touted by Trump may not alleviate pandemic’s toll on the poor

By Emily Kopp
Posted November 24, 2020 at 2:17pm
Pfizer and its partner BioNTech announced that they will submit vaccine data Thursday to the FDA for an emergency authorization.

Virus vaccination timeline depends on variety of factors

By Emily Kopp
Posted November 20, 2020 at 10:37am
Dr. Francis Collins, special project adviser to President Joe Biden and former longtime director of the National Institutes of Health, said Monday the administration plans to unveil a national initiative to fight hepatitis C.

Moderna vaccine shows high efficacy as questions about uptake remain

By Emily Kopp
Posted November 16, 2020 at 11:08am
President-elect Joe Biden announced his COVID-19 task force Monday.

Biden announces COVID-19 task force

By Sandhya Raman and Emily Kopp
Posted November 9, 2020 at 9:42am
U.S. Army General Gustave Perna says the U.S. military is helping Operation Warp Speed with things like planning, logistics, augmentation and program support.

Officials clarify military role in coronavirus vaccination amid wariness

By Emily Kopp
Posted November 5, 2020 at 6:30am
A voter is seen at a voting machine on Tuesday, November 3, 2020.

Health care ballot initiative votes see split results

By Emily Kopp and Sandhya Raman
Posted November 4, 2020 at 4:09pm
A marijuana activist wears a marijuana-themed tie at a rally at the U.S. Capitol last year. This year, much of the momentum on the issue has moved to state houses.

Five more states voting this fall on legalizing marijuana

By Emily Kopp
Posted October 21, 2020 at 5:00am

Deep freezers and dry ice for Pfizer vaccine may face shortages

By Emily Kopp
Posted October 13, 2020 at 9:43am
FDA Commissioner Stephen Hahn says any decisions regarding coronavirus vaccine standards would be made by the agency’s career scientists without any outside influence.

FDA releases high coronavirus vaccine standards despite White House resistance

By Andrew Siddons and Emily Kopp
Posted October 6, 2020 at 3:56pm
Marine One with President Donald Trump flies over a crowd gathered outside of Walter Reed National Medical Center on Monday.

Trump’s antibody drug out of reach for all but ‘rare’ cases

By Emily Kopp
Posted October 6, 2020 at 3:20pm
CDC Director Robert Redfield watches a video monitor before a House Appropriations subcommittee hearing on June 4, 2020.

States push for more funds and guidance on vaccine distribution

By Emily Kopp
Posted September 30, 2020 at 5:29am
President Donald Trump says “at least 100 million vaccine doses” will be manufactured before the end of the year, an estimate that exceeds the CDC’s most optimistic projections.

Trump contradicts CDC, pledging 100 million vaccines in 2020

By Emily Kopp
Posted September 18, 2020 at 5:38pm
Governors, including New York's Andrew Cuomo, are publicly raising doubts about the FDA and the CDC's ability to withstand pressure from President Donald Trump to develop a coronavirus vaccine with record speed.

Exclusive: States plan to independently vet COVID-19 vaccine data

By Emily Kopp
Posted September 17, 2020 at 8:51am
Surgeon General Jerome Adams, left, and National Institutes of Health Director Francis Collins bump elbows after testifying before the Senate Health, Education, Labor and Pensions Committee hearing on Wedenesday in Washington.

Surgeon general, NIH director try to promote public confidence in coronavirus vaccine

By Emily Kopp
Posted September 9, 2020 at 4:17pm
Nurse Jose Muniz administers a shot to a patient taking part in a COVID-19 vaccine study at Research Centers of America in Hollywood, Florida, last month.

Doctors’ fees may mean a ‘free’ COVID-19 vaccine isn’t free

By Emily Kopp
Posted September 2, 2020 at 6:30am
Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, left, and CDC Director Robert Redfield.

Exclusive: Federal officials launch vaccine pilot program

By Emily Kopp
Posted August 10, 2020 at 10:33am
Dr. Anthony Fauci, left, director of the National Institute for Allergy and Infectious Diseases, and CDC Director Dr. Robert Redfield before a Senate hearing in June.

Experts: Daily life may remain disrupted after vaccine launch

By Emily Kopp
Posted July 23, 2020 at 7:00am
The area around the name tag for the Director of the National Institute for Allergy and Infectious Diseases Dr. Anthony Fauci is sanitized before he arrives to testify before the House Committee on Energy and Commerce on the Trump Administration's Response to the COVID-19 Pandemic, on Capitol Hill in Washington, DC on Tuesday, June 23, 2020. Photo by Kevin Dietsch/UPI/POOL

A COVID-19 vaccine won’t mean an immediate return to normal

By Emily Kopp and Thomas McKinless
Posted July 23, 2020 at 6:00am
Rep. Jan Schakowsky, D-Ill., shown talking with reporters in the Capitol, quizzed drug executives at a subcommittee hearing Tuesday on whether their agreements with the federal government ensure that any COVID-19 vaccine will be affordable.

Lawmakers ask about potential COVID-19 vaccine cost, efficacy

By Emily Kopp
Posted July 21, 2020 at 4:23pm